This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R.sup.1-R.sup.7, X.sup.1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.